Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"—either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, ...
Nov 17, 2020
0
1
A less-invasive treatment technique called hemi-gland cryoablation (HGCryo)—destroying the areas of the prostate where cancers are located by freezing them—provides a high rate of effective prostate cancer control, according ...
Sep 28, 2020
0
11
Scientists have developed a simple blood test that can show which men with the most aggressive type of prostate cancer should respond to conventional therapy, and those who need other options.
Jul 7, 2020
0
4
Prostate MRI is an emerging technology used to identify and guide treatment for prostate cancer and has recently gained wide acceptance at many institutions. However, there has been concern that different institutions perform ...
Jun 30, 2020
0
3
The Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) has recently conducted a global survey to examine the impact of the COVID-19 pandemic on urological care. This is the world's first survey of its ...
Jun 19, 2020
0
0
A new blood test can predict how well men with advanced prostate cancer will respond to treatment and could replace some of the existing methods used to characterise and track the disease.
Jun 1, 2020
0
9
Researchers at the University of Cincinnati have found in a retrospective study that African-American men are less likely to use a more targeted biopsy option for prostate cancer, despite an increased incidence in this group ...
Mar 17, 2020
0
1
Unnecessary prostate cancer biopsies could be reduced by 60 per cent thanks to new research from the University of East Anglia.
Mar 10, 2020
0
249
A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. This method, which combines ...
Mar 4, 2020
0
8
(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to ...
Nov 7, 2019
0
2
